Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac potassium and lidocaine for pain during HSG
NCT02709590Phase 3
Key facts
- Status
- Completed
- Start
- Mar 2016
- Primary completion
- Jun 2016
- Countries
- 1
- Sponsor
- Assiut University
- Modality
- Small Molecules
- Conditions
- pain
01
Overview
Phase 3, randomised, double-blind trial of diclofenac and lidocaine 10% oropharyngeal spray in pain (2 arms), sponsored by Assiut University. Primary endpoint: Mean pain score during hysterosalpingography by visual analog scale. Started Mar 2016; status: completed.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Experimental Group
Oral diclofenac potassium + cervical lidocaine cream.
Placebo Group
Oral placebo tablet + cervical placebo cream.
03
Who it enrols
Women undergoing hysterosalpingography without contraindications to the procedure.
04
Endpoints
Primary
Mean pain score during hysterosalpingography by visual analog scale
Secondary
Mean pain score after hysterosalpingography
Side effects of medication
Beyond the preview
Go deeper on NCT02709590.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02709590.